- Utilizing Ascletis' Peptide Oral Transport ENhancement Technology (POTENT), ASC36 oral tablets achieved absolute oral bioavailability of 6% to 8% at steady state, in non-human primate (NHP) studies.
A study published in the journal Science Translational Medicine describes the development and validation of an octopus sucker-inspired buccal mucosa suction patch as a novel drug delivery system. The ...
Learn how bioavailability can be determined in vitro using human cells Discover how gut-liver MPS can be used to evaluate a key ADME parameter Discuss the application of mathematical modeling to ...
A multicenter phase II trial of gefitinib 500 mg/day in 193 patients with advanced epidermal growth factor receptor-positive solid tumors who had failed previous chemotherapy: Interim data ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results